Incannex Healthcare Inc. (IXHL): Total Assets
$20.45M
As of 2025-06-30
$80.28M
As of 2026-03-31
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-06-30 | $20.45M | +19.9% | 2025-09-29, Balance as of period end |
| 2024-06-30 | $17.05M | -28.3% | 2025-09-29, Balance as of period end |
| 2023-06-30 | $23.78M | n/a | 2024-09-30, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | $20.45M | +19.9% |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $51.77M | -32.7% |
| iBio, Inc. (IBIO) | 2026-06-30 | $99.11M | +327.5% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $7.61M | +2.6% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $74.31M | -34.4% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $56.08M | -44.6% |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $2.81M | -49.4% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $116.46M | -22.7% |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $6.95M | +3.4% |
Compare IXHL, ATNM, IBIO, SILO side by side · Screen every company in Pharmaceutical Preparations ↗